Description
The Symposium on “Ovarian Cancer: State of the Art and Future Directions” intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The Symposium will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.

The symposium will discuss recent advances in surgery and cytotoxic chemotherapy, antiangiogenic therapy, therapy targeting signaling pathways, immune therapy, biological and gene therapy, biomarker discovery and disease classification using genomic, and proteomic techniques as well as hereditary ovarian cancer and disease modeling.

Target Audience
This Symposium is directed primarily toward gynecologic oncologists, medical oncologists, basic scientists, translational researchers, and others with an interest in new developments in the treatment of ovarian cancer. Clinicians or scientists in training, nurses, and pharmacists are also invited to attend. Traveling awards will be made available for clinicians or scientists in training.

Topics
• Advances in Cytotoxic Chemotherapy
• Targeted Molecular Therapy
• Advances in Surgery
• Angiogenesis Therapy
• Immune Therapy
• Detection / Biomarkers
• Models of disease

Round Tables
• The next phase-III trials in ovarian cancer International collaborations
• Combinatorial therapy in ovarian cancer
• Accelerating the pace to biomarker discovery

Travel Awards
• Travel grants will be provided for clinical or research fellows in training submitting meritorious Abstracts (based on funding)